TEL
+ 86-21-6420 0566
Код каталога 80017130
CAS NO.158681-13-1
Чистота 98%
Номер MDLMFCD00934884
EINEC Molecular FormulaC22H21Cl3N4O.HCl
Молекулярный вес 500.2483
| Аспект | Подробнее |
|---|---|
| Химическая структура | Rimonabant HCl has the molecular formula C₂₂H₂₂Cl₄N₄O. Its IUPAC name is 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide hydrochloride. |
| Механизм действия | Rimonabant is a potent and selective CB₁ cannabinoid receptor antagonist. It blocks the CB₁ receptor, which is involved in regulating appetite and other behaviors. At higher concentrations, it also inhibits Gαi/o-type G proteins, resulting in a receptor-independent block of G protein signaling. |
| Клиническое использование | It was developed as an anti-obesity drug to be used in conjunction with diet and exercise for patients with a BMI greater than 30 kg/m² or those with a BMI greater than 27 kg/m² with associated risk factors such as type 2 diabetes or dyslipidemia. |
| Условия хранения | Хранить при температуре 2–8°C. |
| Фармакокинетика | Rimonabant has a long biological half-life of 6–9 days in individuals with normal BMI and up to 16 days in those with a BMI greater than 30. It is metabolized in the liver, primarily via the CYP3A4 enzyme. |
| Побочные эффекты | Common side effects include depression, anxiety, nausea, and dizziness. These adverse effects led to its withdrawal from the market in some countries. |
| Нормативный статус | Although it showed promise in clinical trials for weight loss and metabolic improvements, its use was restricted due to significant psychiatric side effects. |
Отказ от ответственности: приведенный выше контент предназначен только для справки и общения среди инсайдеров отрасли и не гарантирует его точность или полноту. Согласно соответствующим законам и правилам, а также правилам этого веб-сайта, подразделения или лица, которые покупают соответствующие товары, должны получить действительные квалификации и условия квалификации.
Фабрика и отгрузка
